Matt Szapacs

Trypsin/Lys-C protease mix for enhanced protein mass spectrometry analysis

Sergei Saveliev, Mark Bratz, Roman A. Zubarev et al. · Nature Methods · 2013 · 74 citations

Life Sciences, Biochemistry, Molecular Biology +13

2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid &amp; Rare Matrices; Regulatory Inputs ( <u>Part 1A</u> – Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC &amp; <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)

Surinder Kaur, Stephen C. Alley, Matt Szapacs et al. · Bioanalysis · 2022 · 29 citations · Full text

Pharmacy, Biochemistry, Biomedical Sciences +15

The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

Kevin S. Thorneloe, Armin Sepp, Sean X. Zhang et al. · EJNMMI Research · 2019 · 23 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +17

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline &amp; Global Harmonization; Hybrid Assays; Oligonucleotides &amp; ADC; Non-Liquid &amp; Rare Matrices; Regulatory Inputs ( <u>Part 1A</u> – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline &amp; Global Harmonization <u>Part 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)

Matt Szapacs, Wenying Jian, Daniel S. Spellman et al. · Bioanalysis · 2023 · 17 citations

Pharmacy, Biomedical Sciences, Analytical Toxicology +13